Related Experiment Videos
[What you always wanted to know about HbA1c]
C Stettler1, B Mueller, P Diem
1Abteilung für Endokrinologie und Diabetologie, Universität Bern, Inselspital.
Schweizerische Medizinische Wochenschrift
|September 20, 2000
Summary
Hemoglobin A1c (HbA1c) measures long-term blood glucose control in diabetes. Standardization of HbA1c testing is crucial due to variations in assay methods and potential interferences affecting results.
Area of Science:
- Clinical Chemistry
- Diabetology
- Laboratory Medicine
Background:
- Hemoglobin A1c (HbA1c) forms from nonenzymatic glycation of hemoglobin, directly correlating with blood glucose levels.
- HbA1c is a key biomarker for assessing long-term glycemic control and predicting diabetes-related complications.
Purpose of the Study:
- To highlight the importance of HbA1c standardization in diabetes management.
- To inform clinicians about factors influencing HbA1c results and the need for assay awareness.
Main Methods:
- Review of current HbA1c assay techniques including ion-exchange chromatography, electrophoresis, affinity chromatography, and immunoassays.
- Discussion of variability in glycohemoglobin assay methods and their impact on reported values.
Main Results:
- Significant variation exists between different HbA1c assays and laboratories, impacting the interpretation of glycemic control.
- Factors such as hemoglobinopathies, anemia, renal failure, and alcohol ingestion can interfere with HbA1c measurements.
Conclusions:
- International standardization of HbA1c testing is essential for accurate and consistent patient management.
- Clinicians must be aware of the specific assay method, reference intervals, and potential interferences when interpreting HbA1c results.